TY - JOUR T1 - Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis JO - Archivos de la Sociedad Española de Oftalmología (English Edition) T2 - AU - Sánchez Ramón,A. AU - Piñón Mosquera,R. AU - Mendieta Rasos,N. SN - 21735794 M3 - 10.1016/j.oftale.2018.07.010 DO - 10.1016/j.oftale.2018.07.010 UR - https://www.elsevier.es/en-revista-archivos-sociedad-espanola-oftalmologia-english-496-articulo-response-anti-vegf-therapy-in-macular-S2173579418301725 AB - A 55 year-old female patient with unilateral acute retinal necrosis (ARN) developed macular oedema (MO) after the resolution of her necrosis. The macular oedema (MO) was managed and controlled for four years with intravitreal anti-VEGF injections. Anti-VEGF therapy could be useful for the treatment of MO secondary to ARN, the same as for treating MO resulting from panuveitis, where its efficacy has been already demonstrated. ER -